Tilray Brands, Inc. reported a 34% YoY revenue increase in Q2 fiscal 2024, reaching $194 million. The growth was driven by a 35% increase in cannabis net revenue, a 117% increase in beverage alcohol net revenue, and a rise in distribution net revenue. Gross profit rose 11% to $47 million, and adjusted EBITDA was positive at $10.1 million. The company reduced its net loss and continued to expand its business, including medical cannabis in Europe and the craft beverage-alcohol market in the U.S. Shares of Tilray traded 5.56% higher at $2.47 in pre-market.